Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer’s disease: blood–brain barrier transport, formulation strategies and therapeutic applications
Collectively, nanocarrier-mediated curcumin delivery represents a promising pharmaceutical strategy to improve brain-specific bioavailability and enable effective multitarget therapeutic intervention in AD.